YM
Yash Mehra Mohan
About Yash Mehra Mohan
Data last updated:
Yash Mehra Mohan is a Director at Ulberto Pharma Private Limited (since 2019), Director at Uvan Pharmaceuticals Private Limited (since 2018) and Director at Indimonk Remedies Private Limited (since 2022), and holds 2 more current directorships. The companies operate in Chemicals and Food And Beverages. The 4 current companies with reported revenue have a combined latest revenue of ₹3.48 Cr; the largest is Ulberto Pharma Private Limited at ₹1.50 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 May 2019 | 2019 | ₹1.50 Cr (FY 2025) | Active | |
| Director | 16 Mar 2018 | 2018 | ₹98.3 Lakh (FY 2025) | Active | |
| Director | 29 Mar 2022 | 2022 | ₹53.1 Lakh (FY 2025) | Active | |
| Director | 14 Dec 2017 | 2017 | ₹47.2 Lakh (FY 2025) | Active | |
| Whole-Time Director | 07 Mar 2024 | 2024 | Active |
Board colleagues of Yash Mehra Mohan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anu Mehra | 08441461 | Ulberto Pharma Private Limited , Indimonk Remedies Private Limited and 2 more | Director |
| Manoj Paliwal | 09430546 | Uvan Pharmaceuticals Private Limited , Indimonk Remedies Private Limited and 1 more | Director |
| Harsh Sethi | 10539627 | Uvamonk Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yash Mehra Mohan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yash Mehra Mohan
Yash Mehra Mohan currently holds 5 directorships: Ulberto Pharma Private Limited (Director, since 02 May 2019, revenue ₹1.50 Cr (FY 2025)); Uvan Pharmaceuticals Private Limited (Director, since 16 Mar 2018, revenue ₹98.3 Lakh (FY 2025)); Indimonk Remedies Private Limited (Director, since 29 Mar 2022, revenue ₹53.1 Lakh (FY 2025)); Yashved Remedies Private Limited (Director, since 14 Dec 2017, revenue ₹47.2 Lakh (FY 2025)); Uvamonk Private Limited (Whole-Time Director, since 07 Mar 2024).
Yash Mehra Mohan was first appointed on 14 Dec 2017 as Director at Yashved Remedies Private Limited. The most recent appointment on record is 07 Mar 2024 at Uvamonk Private Limited.
The 4 current companies of Yash Mehra Mohan that report revenue have a combined latest revenue of ₹3.48 Cr: Ulberto Pharma Private Limited ₹1.50 Cr (FY 2025); Uvan Pharmaceuticals Private Limited ₹98.3 Lakh (FY 2025); Indimonk Remedies Private Limited ₹53.1 Lakh (FY 2025); Yashved Remedies Private Limited ₹47.2 Lakh (FY 2025).
The current boards of Yash Mehra Mohan's companies include Anu Mehra (Ulberto Pharma Private Limited), Manoj Paliwal (Uvan Pharmaceuticals Private Limited), Harsh Sethi (Uvamonk Private Limited).